View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nab-Paclitaxel 100 / Carboplatin 2 / Bevacizumab 10, Breast Ca (tripel-negative)
Protocol-ID: 466 V1.0 (Mini), NPAC100/CRBP2/BEVA10, Breast Ca (tripel-neg.)Indication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
Links
- Paclitaxel formulated as albumin bound nanoparticles [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 31.08.2015